Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 121 AL 135

Targeting Neuroinflammation as Disease Modifying Approach to Alzheimer's Disease: Potential and Challenges

Jain S, Singh R, Paliwal S, Sharma S.

Mini Rev Med Chem. 2023;23(22):2097-2116. doi: 10.2174/1389557523666230511122435.

CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease

Bivona G, Iemmolo M, Ghersi G.

Int J Mol Sci. 2023 May 4;24(9):8230. doi: 10.3390/ijms24098230.

Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer's Disease: Finding Potential Therapeutic Targets

Song M, Fan X.

Int J Mol Sci. 2023 May 7;24(9):8398. doi: 10.3390/ijms24098398.

Designing multi-target drugs for the treatment of major depressive disorder

Halder AK, Mitra S, Cordeiro MNDS.

Expert Opin Drug Discov. 2023 Jun;18(6):643-658. doi: 10.1080/17460441.2023.2214361. Epub 2023 May 19.

Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues

Kumari S, Dhapola R, Reddy DH.

Apoptosis. 2023 Aug;28(7-8):943-957. doi: 10.1007/s10495-023-01848-y. Epub 2023 Apr 26.

[Anti-Dementia Drugs (Anti-Alzheimer's Disease Drugs)]

Yamada M.

Brain Nerve. 2023 May;75(5):464-469. doi: 10.11477/mf.1416202360.

ALZHEIMER'S DISEASE AND ITS RELATIONSHIP WITH THE MICROBIOTA-GUT-BRAIN AXIS

Faulin TDES, Estadella D.

Arq Gastroenterol. 2023 Jan-Mar;60(1):144-154. doi: 10.1590/S0004-2803.202301000-17.

Treatment for Alzheimer's disease: time to get ready

The Lancet Neurology.

Lancet Neurol. 2023 Jun;22(6):455. doi: 10.1016/S1474-4422(23)00167-9.

The Time for Combination Therapy Research in Alzheimer's Disease is Now

Dinnerstein E.

J Alzheimers Dis. 2023;93(3):925-926. doi: 10.3233/JAD-230254.

Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs

Thakral S, Yadav A, Singh V, Kumar M, Kumar P, Narang R, Sudhakar K, Verma A, Khalilullah H, Jaremko M, Emwas AH.

Ageing Res Rev. 2023 Jul;88:101960. doi: 10.1016/j.arr.2023.101960. Epub 2023 May 22.

Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA review

Dickson SP, Hennessey S, Nicodemus Johnson J, Knowlton N, Hendrix SB.

Alzheimers Res Ther. 2023 May 24;15(1):98. doi: 10.1186/s13195-023-01238-1.

Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches

Sun YY, Wang Z, Huang HC.

Cell Mol Neurobiol. 2023 Oct;43(7):3115-3136. doi: 10.1007/s10571-023-01365-1. Epub 2023 May 25.

Therapeutic potential of flavonoids in the management of obesity-induced Alzheimer's disease: an overview of preclinical and clinical studies

Kothawade SM, Buttar HS, Tuli HS, Kaur G.

Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):2813-2830. doi: 10.1007/s00210-023-02529-y. Epub 2023 May 25.

Pharmacological Attributes of Fenugreek with Special Reference to Alzheimer's Disease

Varshney H, Siddique YH.

Curr Alzheimer Res. 2023;20(2):71-79. doi: 10.2174/1567205020666230525154300.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias